Global Intravenous Injection General Anesthesia Drugs market size is predicted to grow from US$ 1850 million in 2025 to US$ 2705 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031. Get Access Now!

Global Intravenous Injection General Anesthesia Drugs Market Growth Status and Outlook 2025-2031

The global Intravenous Injection General Anesthesia Drugs market size is predicted to grow from US$ 1850 million in 2025 to US$ 2705 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031. Intravenous general anesthesia refers to a method in which one or several drugs are injected intravenously and act on the central nervous system through blood circulation to produce general anesthesia. According to different administration methods, intravenous anesthesia can be divided into single administration method, divided administration method and continuous administration method. Due to some limitations of its own, the use of intravenous general anesthesia was once limited. However, since the 1980s, with the continuous improvement of clinical pharmacology research methods, the development of new strong and short-acting intravenous anesthetics and the advent of computerized intravenous automatic drug delivery systems, intravenous anesthesia has been greatly improved. And development, has now become the mainstream general anesthesia solution. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Intravenous Injection General Anesthesia Drugs Industry Forecast looks at past sales and reviews total world Intravenous Injection General Anesthesia Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Intravenous Injection General Anesthesia Drugs sales for 2025 through 2031. With Intravenous Injection General Anesthesia Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Injection General Anesthesia Drugs industry. This Insight Report provides a comprehensive analysis of the global Intravenous Injection General Anesthesia Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Injection General Anesthesia Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Intravenous Injection General Anesthesia Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Injection General Anesthesia Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Injection General Anesthesia Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Injection General Anesthesia Drugs market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Propofol &nbsp;&nbsp;&nbsp; Sevoflurane &nbsp;&nbsp;&nbsp; Remifentanil &nbsp;&nbsp;&nbsp; Etomidate &nbsp;&nbsp;&nbsp; Isoflurane &nbsp;&nbsp;&nbsp; Other Segmentation by Application: &nbsp;&nbsp;&nbsp; Hopitals &nbsp;&nbsp;&nbsp; Clinics &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Aspen Pharma &nbsp;&nbsp;&nbsp; Fresenius-Kabi &nbsp;&nbsp;&nbsp; AbbVie &nbsp;&nbsp;&nbsp; Baxter Healthcare &nbsp;&nbsp;&nbsp; B.Braun &nbsp;&nbsp;&nbsp; Maruishi &nbsp;&nbsp;&nbsp; Piramal &nbsp;&nbsp;&nbsp; Hikma Pharmaceuticals &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; Nhwa &nbsp;&nbsp;&nbsp; Hengrui &nbsp;&nbsp;&nbsp; Xian Libang &nbsp;&nbsp;&nbsp; Yichang Humanwell &nbsp;&nbsp;&nbsp; China National Medicines Guorui Pharmaceutical Co.,Ltd. &nbsp;&nbsp;&nbsp; Maruishi &nbsp;&nbsp;&nbsp; Lunan Pharmaceutical Group Corporation Key Questions Addressed in this Report What is the 10-year outlook for the global Intravenous Injection General Anesthesia Drugs market? What factors are driving Intravenous Injection General Anesthesia Drugs market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Intravenous Injection General Anesthesia Drugs market opportunities vary by end market size? How does Intravenous Injection General Anesthesia Drugs break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Intravenous Injection General Anesthesia Drugs Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Intravenous Injection General Anesthesia Drugs by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Intravenous Injection General Anesthesia Drugs by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Intravenous Injection General Anesthesia Drugs Segment by Type &nbsp;2.2.1 Propofol &nbsp;2.2.2 Sevoflurane &nbsp;2.2.3 Remifentanil &nbsp;2.2.4 Etomidate &nbsp;2.2.5 Isoflurane &nbsp;2.2.6 Other &nbsp;2.3 Intravenous Injection General Anesthesia Drugs Sales by Type &nbsp;2.3.1 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Intravenous Injection General Anesthesia Drugs Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Intravenous Injection General Anesthesia Drugs Sale Price by Type (2020-2025) &nbsp;2.4 Intravenous Injection General Anesthesia Drugs Segment by Application &nbsp;2.4.1 Hopitals &nbsp;2.4.2 Clinics &nbsp;2.4.3 Others &nbsp;2.5 Intravenous Injection General Anesthesia Drugs Sales by Application &nbsp;2.5.1 Global Intravenous Injection General Anesthesia Drugs Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Intravenous Injection General Anesthesia Drugs Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Intravenous Injection General Anesthesia Drugs Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Intravenous Injection General Anesthesia Drugs Breakdown Data by Company &nbsp;3.1.1 Global Intravenous Injection General Anesthesia Drugs Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Intravenous Injection General Anesthesia Drugs Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Company (2020-2025) &nbsp;3.2.2 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Intravenous Injection General Anesthesia Drugs Sale Price by Company &nbsp;3.4 Key Manufacturers Intravenous Injection General Anesthesia Drugs Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Intravenous Injection General Anesthesia Drugs Product Location Distribution &nbsp;3.4.2 Players Intravenous Injection General Anesthesia Drugs Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Intravenous Injection General Anesthesia Drugs by Geographic Region &nbsp;4.1 World Historic Intravenous Injection General Anesthesia Drugs Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Intravenous Injection General Anesthesia Drugs Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Intravenous Injection General Anesthesia Drugs Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Intravenous Injection General Anesthesia Drugs Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Intravenous Injection General Anesthesia Drugs Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Intravenous Injection General Anesthesia Drugs Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Intravenous Injection General Anesthesia Drugs Sales Growth &nbsp;4.4 APAC Intravenous Injection General Anesthesia Drugs Sales Growth &nbsp;4.5 Europe Intravenous Injection General Anesthesia Drugs Sales Growth &nbsp;4.6 Middle East & Africa Intravenous Injection General Anesthesia Drugs Sales Growth 5 Americas &nbsp;5.1 Americas Intravenous Injection General Anesthesia Drugs Sales by Country &nbsp;5.1.1 Americas Intravenous Injection General Anesthesia Drugs Sales by Country (2020-2025) &nbsp;5.1.2 Americas Intravenous Injection General Anesthesia Drugs Revenue by Country (2020-2025) &nbsp;5.2 Americas Intravenous Injection General Anesthesia Drugs Sales by Type (2020-2025) &nbsp;5.3 Americas Intravenous Injection General Anesthesia Drugs Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Intravenous Injection General Anesthesia Drugs Sales by Region &nbsp;6.1.1 APAC Intravenous Injection General Anesthesia Drugs Sales by Region (2020-2025) &nbsp;6.1.2 APAC Intravenous Injection General Anesthesia Drugs Revenue by Region (2020-2025) &nbsp;6.2 APAC Intravenous Injection General Anesthesia Drugs Sales by Type (2020-2025) &nbsp;6.3 APAC Intravenous Injection General Anesthesia Drugs Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Intravenous Injection General Anesthesia Drugs by Country &nbsp;7.1.1 Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2020-2025) &nbsp;7.1.2 Europe Intravenous Injection General Anesthesia Drugs Revenue by Country (2020-2025) &nbsp;7.2 Europe Intravenous Injection General Anesthesia Drugs Sales by Type (2020-2025) &nbsp;7.3 Europe Intravenous Injection General Anesthesia Drugs Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Intravenous Injection General Anesthesia Drugs by Country &nbsp;8.1.1 Middle East & Africa Intravenous Injection General Anesthesia Drugs Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Intravenous Injection General Anesthesia Drugs Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Intravenous Injection General Anesthesia Drugs Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Intravenous Injection General Anesthesia Drugs Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Intravenous Injection General Anesthesia Drugs &nbsp;10.3 Manufacturing Process Analysis of Intravenous Injection General Anesthesia Drugs &nbsp;10.4 Industry Chain Structure of Intravenous Injection General Anesthesia Drugs 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Intravenous Injection General Anesthesia Drugs Distributors &nbsp;11.3 Intravenous Injection General Anesthesia Drugs Customer 12 World Forecast Review for Intravenous Injection General Anesthesia Drugs by Geographic Region &nbsp;12.1 Global Intravenous Injection General Anesthesia Drugs Market Size Forecast by Region &nbsp;12.1.1 Global Intravenous Injection General Anesthesia Drugs Forecast by Region (2026-2031) &nbsp;12.1.2 Global Intravenous Injection General Anesthesia Drugs Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Intravenous Injection General Anesthesia Drugs Forecast by Type (2026-2031) &nbsp;12.7 Global Intravenous Injection General Anesthesia Drugs Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Aspen Pharma &nbsp;13.1.1 Aspen Pharma Company Information &nbsp;13.1.2 Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.1.3 Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Aspen Pharma Main Business Overview &nbsp;13.1.5 Aspen Pharma Latest Developments &nbsp;13.2 Fresenius-Kabi &nbsp;13.2.1 Fresenius-Kabi Company Information &nbsp;13.2.2 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.2.3 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Fresenius-Kabi Main Business Overview &nbsp;13.2.5 Fresenius-Kabi Latest Developments &nbsp;13.3 AbbVie &nbsp;13.3.1 AbbVie Company Information &nbsp;13.3.2 AbbVie Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.3.3 AbbVie Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 AbbVie Main Business Overview &nbsp;13.3.5 AbbVie Latest Developments &nbsp;13.4 Baxter Healthcare &nbsp;13.4.1 Baxter Healthcare Company Information &nbsp;13.4.2 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.4.3 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Baxter Healthcare Main Business Overview &nbsp;13.4.5 Baxter Healthcare Latest Developments &nbsp;13.5 B.Braun &nbsp;13.5.1 B.Braun Company Information &nbsp;13.5.2 B.Braun Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.5.3 B.Braun Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 B.Braun Main Business Overview &nbsp;13.5.5 B.Braun Latest Developments &nbsp;13.6 Maruishi &nbsp;13.6.1 Maruishi Company Information &nbsp;13.6.2 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.6.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Maruishi Main Business Overview &nbsp;13.6.5 Maruishi Latest Developments &nbsp;13.7 Piramal &nbsp;13.7.1 Piramal Company Information &nbsp;13.7.2 Piramal Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.7.3 Piramal Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Piramal Main Business Overview &nbsp;13.7.5 Piramal Latest Developments &nbsp;13.8 Hikma Pharmaceuticals &nbsp;13.8.1 Hikma Pharmaceuticals Company Information &nbsp;13.8.2 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.8.3 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Hikma Pharmaceuticals Main Business Overview &nbsp;13.8.5 Hikma Pharmaceuticals Latest Developments &nbsp;13.9 AstraZeneca &nbsp;13.9.1 AstraZeneca Company Information &nbsp;13.9.2 AstraZeneca Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.9.3 AstraZeneca Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 AstraZeneca Main Business Overview &nbsp;13.9.5 AstraZeneca Latest Developments &nbsp;13.10 Nhwa &nbsp;13.10.1 Nhwa Company Information &nbsp;13.10.2 Nhwa Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.10.3 Nhwa Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Nhwa Main Business Overview &nbsp;13.10.5 Nhwa Latest Developments &nbsp;13.11 Hengrui &nbsp;13.11.1 Hengrui Company Information &nbsp;13.11.2 Hengrui Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.11.3 Hengrui Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Hengrui Main Business Overview &nbsp;13.11.5 Hengrui Latest Developments &nbsp;13.12 Xi'an Libang &nbsp;13.12.1 Xi'an Libang Company Information &nbsp;13.12.2 Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.12.3 Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Xi'an Libang Main Business Overview &nbsp;13.12.5 Xi'an Libang Latest Developments &nbsp;13.13 Yichang Humanwell &nbsp;13.13.1 Yichang Humanwell Company Information &nbsp;13.13.2 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.13.3 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Yichang Humanwell Main Business Overview &nbsp;13.13.5 Yichang Humanwell Latest Developments &nbsp;13.14 China National Medicines Guorui Pharmaceutical Co.,Ltd. &nbsp;13.14.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information &nbsp;13.14.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.14.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Main Business Overview &nbsp;13.14.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Latest Developments &nbsp;13.15 Maruishi &nbsp;13.15.1 Maruishi Company Information &nbsp;13.15.2 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.15.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.15.4 Maruishi Main Business Overview &nbsp;13.15.5 Maruishi Latest Developments &nbsp;13.16 Lunan Pharmaceutical Group Corporation &nbsp;13.16.1 Lunan Pharmaceutical Group Corporation Company Information &nbsp;13.16.2 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Portfolios and Specifications &nbsp;13.16.3 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.16.4 Lunan Pharmaceutical Group Corporation Main Business Overview &nbsp;13.16.5 Lunan Pharmaceutical Group Corporation Latest Developments 14 Research Findings and Conclusion

Report	Global Intravenous Injection General Anesthesia Drugs Market Growth 2025-2031
Selected License	Multi ID: LPI36319

Buyer Information

Order Summary